Bypassing the blood-brain barrier to improve brain tumor diagnosis
A collaborative team of NIH-funded researchers is developing a way to obtain DNA shed from brain tumors using focused ultrasound. Their first-in-human study cou
Stay updated with breaking news from Eric Leuthardt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A collaborative team of NIH-funded researchers is developing a way to obtain DNA shed from brain tumors using focused ultrasound. Their first-in-human study cou
A collaborative team of NIH-funded researchers is developing a way to obtain DNA shed from brain tumors using focused ultrasound. Their first-in-human study cou
A method called sonobiopsy releases neurodegenerative disease biomarkers and could be used for the earlier detection of Alzheimer’s disease.
Research from the lab of Hong Chen, at Washington University in St. Louis, and collaborators found that using focused-ultrasound-mediated liquid biopsy in a mouse model released more tau proteins and another biomarker into the blood than without the intervention. This noninvasive method could facilitate diagnosis of neurodegenerative disorders.
Several progressive neurodegenerative disorders, including Alzheimer's disease, are defined by having tau proteins in the brain.